4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001301120-25-000033
Chief Scientific Officer sold 1,700 shares at $3.26 ($5,541)
- Chief Scientific Officer acquired 1,700 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moreadith Randall · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,700 | $0.06 | $102 | 1,700 | D |
| 2025-12-12 | Sale : show line 2 in the form 10b5-1 | −1,700 | $3.26 | $5,541 | 0 | D |
| Open-market sales · 1,700 sh · avg $3.26 · $5,541 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-12 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −1,700 | 365,186 | D |
Loading xslF345X05/wk-form4_1765929561.xml…